Polymorphism of the IRGM Gene Might Predispose to Fistulizing Behavior in Crohn's Disease

Latiano, A.; Palmieri, O.; Cucchiara, S.; Castro, M.; D'Incà, R.; Guariso, G.; Dallapiccola, B.; Valvano, M. R.; Latiano, T.; Andriulli, A.; Annese, V.
January 2009
American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p110
Academic Journal
OBJECTIVES: Recently, genome-wide association analyses have identified single nucleotide polymorphisms in the IRGM gene (rs1000113 and rs4958847) as strong candidate susceptibility factors for Crohn's disease (CD). The aim of our study was to test whether these variants are associated with inflammatory bowel disease (IBD) in adult- and childhood-onset Italian patients. METHODS: Allele and genotype frequencies of rs1000113 and rs4958847 were determined in 823 CD (265 younger than 19 years at diagnosis), 353 ulcerative colitis (UC) (130 younger than 19 years at diagnosis), and 578 controls. Genotype distributions were examined both within IBD clinical sub-phenotypes and CARD15 genotypes. RESULTS: rs1000113 and rs4958847 were both associated with adult-onset (P=2×10-4 ; P=2.5×10-3, respectively) and childhood-onset (P=4×10-4; P=8×10-3, respectively) CD cohorts. Similarly, the genotype frequencies remained significantly different for both variants (adult rs1000113, P=1×10-4; rs4958847, P=1×10-3; pediatric rs1000113, P=2.3×10-4; rs4958847, P=9.6×10-3). At logistic regression, the rs4958847 polymorphism was associated with fistulizing behavior (P=0.037, OR = 1.54, CI = 1.02-2.31) and perianal fistulas (P=0.045, OR = 1.55, CI = 1.01-2.38). Conversely, no association with UC and sub-phenotypes was shown. CONCLUSIONS: We replicated the previously reported associations between CD and rs1000113 and rs4958847, confirming that IRGM is a susceptibility locus only for CD, either adult- or early-onset in the Italian population; furthermore, we have also shown its influence on specific clinical features (fistulizing disease).


Related Articles

  • Genetic adult lactase persistence is associated with risk of Crohn's Disease in a New Zealand population. Nolan, Deborah J.; Dug Yeo Han; Wen Jiun Lam; Morgan, Angharad R.; Fraser, Alan G.; Tapsell, Linda C.; Ferguson, Lynnette R. // BMC Research Notes;2010, Vol. 3, p339 

    Background: Mycobacterium avium subspecies paratuberculosis (MAP) is an infective agent found in ruminants and milk products, which has been suggested to increase the risk of gastrointestinal inflammation in genetically susceptible hosts. It is hypothesized that lactase persistence facilitates...

  • Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Klein, W; Tromm, A; Griga, T; Fricke, H; Folwaczny, C; Hocke, M; Eitner, K; Marx, M; Duerig, N; Epplen, J T // Genes & Immunity;Aug2001, Vol. 2 Issue 5, p287 

    Imbalances in the regulation of Th1 and Th2 lymphocytes are crucial in inflammatory bowel diseases. Interleukin-4 is secreted by Th2 lymphocytes and downregulates cytokine production from Th I lymphocytes. Functionally relevant polymorphisms have been described in the interleukin-4 and the...

  • The CC chemokine receptor 5 Δ32 mutation is not associated with inflammatory bowel disease (IBD) in NE England. Craggs, A; Welfare, M; Donaldson, P T; Mansfield, J C // Genes & Immunity;Apr2001, Vol. 2 Issue 2, p114 

    Inflammatory bowel disease (IBD) is a group of chronic inflammatory diseases of the gastrointestinal tract of unknown aetiology. Evidence of abnormalities in immune regulation and cytokine production in patients with IBD has led to investigations of various immuno-regulatory genes as potential...

  • Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis. Karlsen, Tom H.; Hampe, Jochen; Wiencke, Kristine; Schrumpf, Erik; Thorsby, Erik; Lie, Benedicte A.; Broomé, Ulrika; Schreiber, Stefan; Boberg, Kirsten Muri // American Journal of Gastroenterology;Jan2007, Vol. 102 Issue 1, p115 

    OBJECTIVES: Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have concurrent inflammatory bowel disease (IBD). The majority have ulcerative colitis, but there is also an association with Crohn's colitis. The pathogenetic link between PSC and IBD...

  • Contribution of NKX2-3 Polymorphisms to Inflammatory Bowel Diseases: A Meta-Analysis of 35358 subjects. XiaoCheng Lu; Linjun Tang; Kai Li; JinYu Zheng; Penglai Zhao; Yi Tao; Li-Xin Li // Scientific Reports;1/31/2014, p1 

    Polymorphisms in NKX2-3 gene have been inconsistently associated with Crohn's disease (CD) and ulcerative colitis (UC). To generate large-scale evidence on whether NKX2-3 polymorphisms are associated with CD or UC susceptibility we have conducted a meta-analysis of 17 studies involving 17329...

  • Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. Min Chen; Peyrin-Biroulet, Laurent; Bing Xia; Guéant-Rodriguez, Rosa-Maria; Bronowicki, Jean-Pierre; Bigard, Marc-André; Guéant, Jean-Louis // BMC Medical Genetics;2008, Vol. 9, Special section p1 

    Background: The association of genetic polymorphisms related to metabolism of homocysteine with inflammatory bowel disease has been evidenced in Crohn disease and remains an open question in ulcerative colitis. We evaluated the association of the polymorphisms of MTHFR, MTR, MTRR and TCN2 genes...

  • Inflammatory Bowel Disease: Its Present and Its Future. Kirsner, Joseph B. // American Journal of Gastroenterology;Nov1989, Vol. 84 Issue 11, p1358 

    Discusses the developments in the treatment of inflammatory bowel disease (IBD) as of 2005. Experiment done to determine the treatment for IBD; Pathogenesis of IBD; Microbial cause of IBD.

  • IL23R R381Q and ATG16L1 T300A Are Strongly Associated With Crohn's Disease in a Study of New Zealand Caucasians With Inflammatory Bowel Disease. Roberts, Rebecca L.; Gearry, Richard B.; Hollis-Moffatt, Jade E.; Miller, Allison L.; Reid, Julia; Abkevich, Victor; Timms, Kirsten M.; Gutin, Alexander; Lanchbury, Jerry S.; Merriman, Tony R.; Barclay, Murray L.; Kennedy, Martin A. // American Journal of Gastroenterology;Dec2007, Vol. 102 Issue 12, p2754 

    OBJECTIVE: Recently, separate genome-wide association analyses have identified nonsynonymous SNPs in IL23R and ATG16L1 ( rs11209026; c1142G>A, R381Q, and rs2241880; c1338A>G, T300A, respectively) as strong candidate susceptibility factors for Crohn's disease (CD) in whites. The aim of our study...

  • Natalizumab.  // Reactions Weekly;6/25/2005, Issue 1057, p14 

    Discusses research being done on progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. Reference to a study by G. Van Assche et al published in the 2005 issue of the "New England Journal of Medicine"; Findings of the study.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics